Vibrotactile Coordinated Reset in Parkinson's Disease - Proof of Concept Study
Stanford University
Summary
The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on Parkinson's symptoms. vCR will be administered with a device called the Stanford Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as Levodopa and/or deep brain stimulation. Patients will be followed for 14 months.
Description
The purpose of this study is to test the efficacy of vibrotactile coordinated reset stimulation on human subject participants with Parkinson's disease and inform the investigators on whether unilateral stimulation could be as effective as bilateral stimulation at producing clinically significant improvements in symptoms.
Eligibility
- Age range
- 18–92 years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: Ages 18 or older * Diagnosed with idiopathic Parkinson's Disease * Fluent in English * Off-state UPDRS III motor score at least 30, as assessed within the past 6 months before study consent or at Screening Visit. * Demonstrates understanding of the study requirements and is able and willing to sign the informed consent form and complete study procedures. Exclusion Criteria: * Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days. Any other trial participation should be approved by the Principal Investigators. * Pregnancy,…
Interventions
- DeviceStanford Glove
The non-invasive neuromodulation hardware system comprises two wireless controllers/battery packs which are fastened to the top of each hand via an adjustable elastic strap. Each controller is equipped with four vibrotactile fingertip stimulators, also known as tappers. There is a total of eight tappers (for index, middle, ring and pinkie of each hand) per system.
Location
- Stanford UniversityStanford, California